<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Indian Soc Periodontol</journal-id><journal-id journal-id-type="iso-abbrev">J Indian Soc Periodontol</journal-id><journal-id journal-id-type="publisher-id">JISP</journal-id><journal-title-group><journal-title>Journal of Indian Society of Periodontology</journal-title></journal-title-group><issn pub-type="ppub">0972-124X</issn><issn pub-type="epub">0975-1580</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25425824</article-id><article-id pub-id-type="pmc">4239752</article-id><article-id pub-id-type="publisher-id">JISP-18-618</article-id><article-id pub-id-type="doi">10.4103/0972-124X.142457</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A comparative evaluation of platelet-rich plasma in combination with demineralized freeze-dried bone allograft and DFDBA alone in the treatment of periodontal intrabony defects: A clinicoradiographic study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kukreja</surname><given-names>Bhavna Jha</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Dodwad</surname><given-names>Vidya</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Kukreja</surname><given-names>Pankaj</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Ahuja</surname><given-names>Sakshi</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Mehra</surname><given-names>Praful</given-names></name><xref ref-type="aff" rid="aff4">3</xref></contrib></contrib-group><aff id="aff1"><italic>Department of Periodontology, I.T.S Centre for Dental Studies and Research, Delhi-Meerut Road, Muradnagar, Ghaziabad, Uttar Pradesh, India</italic></aff><aff id="aff2"><label>1</label><italic>Department of Oral and Maxillofacial Surgery, I.T.S Centre for Dental Studies and Research, Delhi-Meerut Road, Muradnagar, Ghaziabad, Uttar Pradesh, India</italic></aff><aff id="aff3"><label>2</label><italic>Department of Private Practice in Periodontology, I.T.S Centre for Dental Studies and Research, Delhi-Meerut Road, Muradnagar, Ghaziabad, Uttar Pradesh, India</italic></aff><aff id="aff4"><label>3</label><italic>Department of Prosthodontics, I.T.S Centre for Dental Studies and Research, Delhi-Meerut Road, Muradnagar, Ghaziabad, Uttar Pradesh, India</italic></aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Bhavna Jha Kukreja, Department of Periodontology, I.T.S Centre for Dental Studies and Research, Delhi-Meerut Road, Muradnagar, Ghaziabad - 201 206, Uttar Pradesh, India. E-mail: <email xlink:href="drbhavnajha@gmail.com">drbhavnajha@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2014</year></pub-date><volume>18</volume><issue>5</issue><fpage>618</fpage><lpage>623</lpage><history><date date-type="received"><day>10</day><month>11</month><year>2013</year></date><date date-type="accepted"><day>10</day><month>2</month><year>2014</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Journal of Indian Society of Periodontology</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>The aim of the present clinical trial was to compare PRP combined with a DFDBA to DFDBA mixed with a normal saline solution in the treatment of human intrabony defects.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>Twenty interproximal intrabony osseous defects in twenty non-smoking, healthy subjects diagnosed with chronic periodontitis were treated in this study. Ten subjects each were randomly assigned to the test group (PRP + DFDBA) or the control group (DFDBA + saline). Clinical and radiographic measurements were made at baseline, three month and at six-month evaluation.</p></sec><sec id="st3"><title>Results:</title><p>The results at three and six months, when compared to the baseline, indicated that both treatment modalities resulted in significant changes in all clinical parameters (gingival index, bleeding on probing, probing depth, clinical attachment level and gingival recession; <italic>P</italic> &#x0003c; 0.01) and radiographic parameters (hard-tissue fill and bone-depth reduction; <italic>P</italic> &#x0003c; 0.01). However, the test group exhibited statistically significantly greater changes compared to the control group in plaque index at three months (<italic>P</italic> = 0.00), probing depth reduction at 6 months (<italic>P</italic> = 0.02) and the radiographic defect fill at 6 months (<italic>P</italic> = 0.01).</p></sec><sec id="st4"><title>Conclusions:</title><p>Treatment with a combination of PRP and DFDBA led to a statistically significantly greater improvement in plaque index at 3 months, probing depth at 6 months and radiographic defect fill at 6 months in intrabony periodontal defects as compared to DFDBA with normal saline.</p></sec></abstract><kwd-group><kwd>Allograft</kwd><kwd>bone</kwd><kwd>defect</kwd><kwd>regeneration</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Periodontal therapy aims to arrest disease progression and regeneration of structures lost to disease.[<xref rid="ref1" ref-type="bibr">1</xref>] Periodontal regeneration requires a sequence of cell migration, adherence, growth and differentiation, which have potential to increase regeneration.[<xref rid="ref2" ref-type="bibr">2</xref>] To be considered a regenerative modality, a material or technique must demonstrate that bone, cementum and a functional periodontal ligament can be formed on a diseased root surface. Only autogenous bone grafts provide viable osteogenic cells.[<xref rid="ref3" ref-type="bibr">3</xref>] Regenerative treatment with bone grafting leads to some degree of regenerated bone, cementum and periodontal ligament.[<xref rid="ref4" ref-type="bibr">4</xref>]</p><p>Platelet-rich plasma (PRP) is an autologous source of PDGF and TGF-&#x003b2; that is obtained by isolating and concentrating human platelets to a high percentage by gradient density centrifugation. PRP has been used successfully to enhance clinical outcome obtained with guided tissue regeneration (GTR) and bone grafts in treatment of intrabony defects.[<xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref>] Platelet gel has been used successfully in combination with DFDBA for treatment of periodontal osseous defects.[<xref rid="ref7" ref-type="bibr">7</xref>] It eliminates concerns about immunogenic reactions and disease transmission.[<xref rid="ref8" ref-type="bibr">8</xref>]</p><p>Although complete periodontal regeneration is unpredictable with any regenerative therapy currently used, periodontal bone grafts show strong potential. A large body of clinical evidence clearly indicates that grafts consistently lead to better bone fill than non-grafted controls.[<xref rid="ref4" ref-type="bibr">4</xref>] DFDBAs have repeatedly demonstrated significant improvements in soft and hard clinical tissue parameters for the treatment of intraosseous periodontal defects. Substances present in the demineralized bone graft material, i.e., bone morphogenic proteins, stimulate local cell cycles to produce new bone. The freeze drying process destroys cells while maintaining cellular morphology and chemical integrity. These two factors, in conjunction with other materials, enhance periodontal regeneration and/or bone fill.[<xref rid="ref1" ref-type="bibr">1</xref>]</p><p>Therefore, the purpose of this study was to compare clinical and radiographic outcomes obtained with combination of PRP and DFDBA to those obtained with DFDBA mixed with saline solution in treatment of periodontal intrabony defects 6 months after flap surgery. Membrane was not used in this study because it was desired to study the effect of PRP on the bony regeneration by DFDBA.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><sec id="sec2-1"><title>Study population</title><p>Twenty patients diagnosed with chronic periodontitis (11 males and 9 females), aged between 20 and 50 years, who reported to the Department of periodontology, I.T.S Centre for Dental Studies and Research, Muradnagar, Ghaziabad, Uttar Pradesh, India, having a total of 20 intrabony defects sites were selected for this comparative clinico-radiographic study. The study subjects signed an informed consent form approved by the ethical committee of I.T.S Centre for dental studies and research.</p></sec><sec id="sec2-2"><title>Study design</title><p>The sample size of 20 patients was determined by a statistical software. Study was designed as a randomized clinical trial comparing periodontal clinical outcomes using DFDBA in combination with autologous PRP preparation (test) or a saline solution (control) in treatment of intrabony defects. Criteria for inclusion were individuals who were systemically healthy, no contraindications to surgery, no abnormal platelet counts, not received antibiotic therapy six months prior to treatment, not received any periodontal therapy for two years, non-smokers, had at least one vertical osseous defects with residual probing pocket depth of &#x0003e;5 mm with radiographic evidence of vertical/angular bone loss in the affected sites (At atleast one site in the quadrant) and had at least 2 mm of keratinized gingiva on facial aspect of selected tooth. Criteria for exclusion were patients allergic or sensitive to any medication and/or local anesthesia. Patients showing unacceptable oral hygiene compliance, pregnant and lactating mothers and teeth with severe attrition and excessive mobility.</p></sec><sec id="sec2-3"><title>Initial therapy (pre-surgical therapy)</title><p>Initial therapy consisted of oral hygiene instructions, scaling and root planing. Patients who met all criteria for entry into surgical phase of therapy were then randomized by a coin toss to test (PRP + DFDBA) or control (DFDBA) study groups.</p></sec><sec id="sec2-4"><title>Measurements of clinical parameters</title><p>At baseline, 3 and 6 months after surgical procedure, plaque index, gingival index, probing pocket depth, clinical attachment level and gingival marginal position were recorded by a single blinded observer using a University of North Carolina 15 (UNC 15) probe and a customized acrylic stent with a guiding groove.[<xref rid="ref9" ref-type="bibr">9</xref>] All customized acrylic stents were stored on prepared study casts throughout study period to minimize distortion.[<xref rid="ref9" ref-type="bibr">9</xref>] Probing pocket depth was recorded by noting the difference between measurements from fixed reference point to gingival margin and to the base of the pocket. Changes in clinical attachment level were recorded by noting the difference between measurements from the distance from fixed reference point to the base of the pocket and from fixed reference point to the cementoenamel junction. Gingival margin position was recorded by noting the difference between measurements from the distance from fixed reference point to the gingival margin and to the cementoenamel junction.</p></sec><sec id="sec2-5"><title>Radiographic assessment</title><p>Intraoral periapical radiographs were taken by long cone/extension cone paralleling technique using a positioning devices and an IOPA X-ray film in an X-ray unit (70 kVp, 4-8 mA, 0.630 mAs). A single grid was used along with all IOPA radiographs for measuring radiographic defect depth. Processing and viewing of the X-ray films were standardized [Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Test Group (PRP+DFDBA) - Preoperative and 6 months postoperative radiograph</p></caption><graphic xlink:href="JISP-18-618-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Control Group (DFDBA + Saline) - Preoperative and 6 months postoperative radiograph</p></caption><graphic xlink:href="JISP-18-618-g002"/></fig><p>Bone defect depth was measured as the distance from the alveolar crest to the base of the bone defect. The base of defect (BOD) was defined as the most coronal point where the periodontal ligament space showed continuous width. The alveolar crest (AC) level was taken as the crossing of the alveolar crest with the root surface.[<xref rid="ref10" ref-type="bibr">10</xref>] The amount of defect fill was the difference between the initial and final defect depths at recalled time interval. Percentage (%) of defect fill was the amount of defect fill/baseline defect depth &#x000d7; 100.[<xref rid="ref11" ref-type="bibr">11</xref>]</p></sec><sec id="sec2-6"><title>Preparation of PRP</title><p>PRP was prepared as described by Marx <italic>et al</italic>.[<xref rid="ref12" ref-type="bibr">12</xref>] Sixteen milliliter of blood was drawn from anticubital region of patients&#x02019; forearm in vaccutainer containing heparin sodium as an anti-coagulant. Whole blood was then centrifuged at 1000 rpm for 10 minutes. The supernatant formed was PRP. PRP, buffy coat and upper 1-2 mm of R.B.C layer was collected in a fresh vaccutainer and again centrifuged at 1000 rpm for 10 minutes. Upper half of supernatant was discarded and lower half was mixed thoroughly to yield PRP. 2.5 ml of PRP was thoroughly mixed with 0.08 ml of CaCl<sub>2</sub>. This resulted in a clot formation and thrombin formation. The clot was discarded and thrombin was used for preparation of PRP. PRP + thrombin at 37&#x000b0;C for 2-3 min led to formation of PRP gel. Human DFDBA with a particle size 500-1000 &#x003bc;m was used as bone graft for all patients.</p></sec><sec id="sec2-7"><title>Treatment procedure</title><p>A standardized surgical procedure using a conventional periodontal flap surgery was performed by a single operator. Site was anesthetized using 2% lignocaine hydrochloride with adrenaline 1:200,000. Intracrevicular incisions were made, mucoperiosteal flaps were elevated and intrabony defects fully exposed. Meticulous defect debridement and root planing were carried out. Care was taken to keep the area free of saliva. Immediately before application PRP was activated by autologous thrombin with 1 ml of 10% CaCl<sub>2</sub>. Within a few seconds, the PRP preparation assumed a sticky gel consistency. Depending on the extent of intrabony osseous defect, coagulated PRP + DFDBA was placed up to vertical height of corresponding adjacent bone level. Surgical flaps were repositioned to presurgical level and sutured with 4-0 silk suture. A periodontal dressing was placed on surgical area. Postoperative medications included a single standard regimen of oral administration of Amoxycillin 500 mg thrice daily for 5 days, Metronidazole 400 mg thrice daily for 5 days and Ibuprofen 400 mg + Paracetamol 325 mg thrice daily for 5 days, along with 0.2% chlorhexidine gluconate rinse twice daily for a period of 2 weeks.</p></sec><sec id="sec2-8"><title>Post-surgical care and post-treatment assessments</title><p>Ten days following surgery, dressings and sutures were removed and patients were asked regarding discomfort, pain and sensitivity. All patients were recalled at one-month interval for check-up. After 3 months and 6 months postoperatively, parameters were recorded again.</p></sec><sec id="sec2-9"><title>Statistical Analysis</title><p>All the clinical parameters and radiographic measurements were subjected to statistical analysis using the statistical package SPSS v. 19. Clinical and radiographic parameters were subjected to Student's &#x02018;<italic>t</italic>&#x02019; test and the &#x02018;<italic>P</italic>&#x02019; values were obtained with appropriate levels of significance i.e., 5%. (statistically significant for <italic>P</italic> &#x02264; 0.05).</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>In the present study, 20 patients of Indian origin (11 males and 9 females, <xref ref-type="fig" rid="F3">Graph 1</xref>) with ages ranging from 20 to 47 years, fulfilling the inclusion and exclusion criteria, contributing to a total of 20 intrabony defects were recruited. These 20 periodontal intrabony defects were then randomly assigned into experimental and control sites. All the preoperative variables were not statistically significant on comparison between the test and the control group, therefore assuring homogenicity between the two groups.</p><fig id="F3" position="float"><label>Graph 1</label><caption><p>Age and sex of the study sample patients</p></caption><graphic xlink:href="JISP-18-618-g003"/></fig><p>The Silness and Loe plaque index values reduction achieved in the test group at 3<sup>rd</sup> and 6<sup>th</sup> months post-surgery was 0.753 &#x000b1; 0.1265 (40.39%), and 1.158 &#x000b1; 0.1671 (62.12%), respectively. The reduction achieved in the control group at 3<sup>rd</sup> and 6<sup>th</sup> months post-surgery was 0.633 &#x000b1; 0.0769 (34.87%) and 1.066 &#x000b1; 0.1414 (58.72%), respectively. The difference between the experimental and control groups with respect to these measurements was statistically highly significant at 3 months (<italic>P</italic> = 0.00) but not significant at 6 months (<italic>P</italic> = 0.45) [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Parameters recorded</p></caption><graphic xlink:href="JISP-18-618-g004"/></table-wrap><p>The Loe and Silness gingival index values reduction achieved in the test group at 3<sup>rd</sup> and 6<sup>th</sup> months post-surgery was 0.712 &#x000b1; 0.1476 (35.02%) and 1.269 &#x000b1; 0.1513 (62.41%), respectively. The reduction achieved in the control group at 3<sup>rd</sup> and 6<sup>th</sup> months post-surgery was 0.548 &#x000b1; 0.1199 (30.02%) and 1.033 &#x000b1; 0.1008 (56.59%), respectively. The difference between the experimental and control groups with respect to these measurements was statistically not significant at 3 months (<italic>P</italic> = 0.59) and at 6 months (<italic>P</italic> = 0.35) [<xref ref-type="table" rid="T1">Table 1</xref>].</p><p>The mean probing depths reduction achieved in the test group at 3<sup>rd</sup> and 6<sup>th</sup> months post-surgery was 2.90 &#x000b1; 0.9944 (41.43%) and 4.1 &#x000b1; 0.9944 (58.57%), respectively. The reduction achieved in the control group at 3<sup>rd</sup> and 6<sup>th</sup> months post-surgery was 2.2 &#x000b1; 1.0328 (22.84%) and 2.6 &#x000b1; 1.1738 (38.81%), respectively. The difference between the experimental and control groups with respect to these measurements were not statistically significant at 3 months (<italic>P</italic> = 0.47) but highly significant at 6 months (<italic>P</italic> = 0.02) [<xref ref-type="table" rid="T1">Table 1</xref>].</p><p>The mean clinical attachment level reduction achieved in test group at 3<sup>rd</sup> and 6<sup>th</sup> months post-surgery was 1.9 &#x000b1; 0.5676 mm (27.94%) and 3 &#x000b1; 1.0541 mm (44.12%), respectively. Reduction achieved in control group at 3<sup>rd</sup> and 6<sup>th</sup> months post-surgery was 1.5 &#x000b1; 0.7071 mm (22.39%) and 2 &#x000b1; 0.6667 mm (29.85%), respectively. Difference between experimental and control groups with respect to these measurements were not statistically significant at 3 months (<italic>P</italic> = 0.6008) and at 6 months (<italic>P</italic> = 0. 134) [<xref ref-type="table" rid="T1">Table 1</xref>].</p><p>Preoperative mean gingival margin position did not have any significant differences (<italic>P</italic> = 0.7263). The reduction achieved in test as well as control groups at 3<sup>rd</sup> and 6<sup>th</sup> months post-surgery was 0.6 &#x000b1; 0.9661 mm (600%). The difference between experimental and control groups with respect to these measurements were not statistically significant at 3 and 6 months (<italic>P</italic> = 0. 24) [<xref ref-type="table" rid="T1">Table 1</xref>].</p><p>There was no statistical significant difference in radiographic bone level between the groups when the baseline (<italic>P</italic> = 0.62) and 3 months (<italic>P</italic> = 0.45) measurements were compared. However, there was a statistically significant difference in the value at 6 months (<italic>P</italic> = 0.01). Mean percentage of bone fill in control group obtained was 24.63%, whereas percentage of bone fill in experiment group was 45.54%, which is 21% more than control group [<xref ref-type="table" rid="T1">Table 1</xref>].</p></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>The ultimate goal of periodontal therapy is creation of an environment that is conducive to maintain dentition in state of optimum health, comfort and function. Schwartz <italic>et al</italic>. have stated that current widespread use of DFDBA is based on its purported osteoinductive ability.[<xref rid="ref13" ref-type="bibr">13</xref>] Histologically, DFDBA has been shown to be more effective in inducing regeneration of periodontium.[<xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref>] Garret has stated that growth factors can provide the additional stimulus.[<xref rid="ref17" ref-type="bibr">17</xref>] Growth factors have pleiotropic effects, are potent modulators of cells residing within the periodontium and have been shown to exert favorable effect on periodontium.[<xref rid="ref18" ref-type="bibr">18</xref>] A simple way to obtain these growth factors is PRP, a rich source of platelet-derived growth factors. PRP combined with hydroxyapatite, bovine porous bone mineral and barrier membranes has been tested in periodontal defects.[<xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref>]</p><p>Human DFDBA with particle size 500-1000 &#x003bc;m was used in present study, as these sizes are recommended. The retention of blood clots is difficult when the between-particle distance is too large, whereas blood vessels cannot readily enter the material when the distance is too small.[<xref rid="ref22" ref-type="bibr">22</xref><xref rid="ref23" ref-type="bibr">23</xref>]</p><p>Our study showed a statistically highly significant change in plaque index of both test and control groups from baseline to 3 months and 6 months. The comparison within the groups showed the change to be significant at 3 months, but not significant at 6 months. A statistically highly significant change in the gingival index of the test and control groups from baseline to 3 months and 6 months was noted. Comparison within the groups showed change to be not significant at 3 months and 6 months. Cortellini <italic>et al</italic>. have stated that such change in index scores may be attributed to good maintenance of oral hygiene by patients throughout the study period.[<xref rid="ref24" ref-type="bibr">24</xref>] Piemontese <italic>et al</italic>., Yukna <italic>et al</italic>. and Srikanth <italic>et al</italic>. have shown similar changes in plaque index and gingival index in their study.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref25" ref-type="bibr">25</xref><xref rid="ref26" ref-type="bibr">26</xref>]</p><p>In the present study, probing pocket depth showed a highly significant reduction in both test and control groups from baseline to 3 months and 6 months. However, comparison within the groups showed change to be not significant at 3 months (<italic>P</italic> = 0.47) but significant at 6 months (<italic>P</italic> = 0.02), which is in accordance with studies by Piemontese <italic>et al</italic>., Richardson <italic>et al</italic>., Bender <italic>et al</italic>. and Hanna <italic>et al</italic>.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref><xref rid="ref29" ref-type="bibr">29</xref>] Greater reduction in Probing Depth observed in test group may be explained by additional biologic effects of PRP. Wikesjo <italic>et al</italic>. have stated that because of its high fibrin content, PRP preparation has a &#x02018;sticky&#x02019; characteristic that works as a hemostatic and stabilizing agent.[<xref rid="ref30" ref-type="bibr">30</xref>] It may aid in immobilizing the blood clot and bone graft in defect area, an important event in early phases of wound healing in periodontal regeneration.</p><p>In the present study, both test and control groups showed a statistically highly significant change in clinical attachment level from baseline to 3 months and 6 months. Comparison within the groups showed change to be not significant at 3 months and 6 months. These results are consistent with studies of Hanna <italic>et al</italic>. and Camargo <italic>et al</italic>.[<xref rid="ref29" ref-type="bibr">29</xref><xref rid="ref31" ref-type="bibr">31</xref>]</p><p>In the present study, test and control groups did not show a statistically significant change in gingival marginal position from baseline to 3 months and 6 months. The comparison within the groups showed change to be not significant at 3 months (<italic>P</italic> = 0.79) and 6 months (<italic>P</italic> = 0.79). Piemontese <italic>et al</italic>. have reported contrasting results.[<xref rid="ref1" ref-type="bibr">1</xref>] However, Park <italic>et al</italic>. and Lovelace <italic>et al</italic>. showed similar recession values, probably due to the fact that these studies were of equal duration i.e., 6 months.[<xref rid="ref32" ref-type="bibr">32</xref><xref rid="ref33" ref-type="bibr">33</xref>] Primary reason for this change after treatment can be attributed to reduction in gingival inflammation and shrinkage of pocket wall.[<xref rid="ref21" ref-type="bibr">21</xref>]</p><p>Radiographic evaluation of experimental and control sites showed progressive changes in appearance of graft material from time of placement to 3 and 6 months. Comparison across the groups also showed results to be not statistically significant at the end of 3 months but highly significant at 6 months. These results are in accordance with a study by Piemontese <italic>et al</italic>.[<xref rid="ref1" ref-type="bibr">1</xref>] However, studies by Okuda <italic>et al</italic>., Aghaloo <italic>et al</italic>. and Wiltfang <italic>et al</italic>. show contrasting results.[<xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref34" ref-type="bibr">34</xref><xref rid="ref35" ref-type="bibr">35</xref>] This may be explained by the fact that growth factors present in high concentrations at inappropriate times or for an extended duration can adversely affect cell behavior.[<xref rid="ref35" ref-type="bibr">35</xref><xref rid="ref36" ref-type="bibr">36</xref>]</p><p>A combination of platelet-rich plasma (PRP), bovine porous bone mineral (BPBM) and guided tissue regeneration (GTR) has been shown to be effective in promoting clinical signs of periodontal regeneration in intrabony defects.[<xref rid="ref5" ref-type="bibr">5</xref>] Camargo <italic>et al</italic>. have evaluated the additional benefits provided by the incorporation of platelet-rich plasma (PRP) into a regenerative protocol consisting of bovine porous bone mineral (BPBM) and guided tissue regeneration (GTR) in the treatment of intrabony defects in humans. They have concluded that PRP did not significantly augment the effects of BPBM and GTR in promoting the clinical resolution of intrabony defects.[<xref rid="ref37" ref-type="bibr">37</xref>] However, recent studies by Lekovic <italic>et al</italic>. indicate that platelet-rich fibrin (PRF) can improve clinical parameters associated with human intrabony periodontal defects, and BPBM has the ability to augment the effects of PRF in reducing pocket depth, improving clinical attachment levels and promoting defect fill.[<xref rid="ref38" ref-type="bibr">38</xref>] On the contrary, Dori <italic>et al</italic>. have shown that at one year after regenerative surgery with PRP + anorganic bovine bone material (ABBM) and ABBM alone, significant probing depth reductions and clinical attachment level gains were found, and the use of PRP failed to improve the results obtained with ABBM alone.[<xref rid="ref39" ref-type="bibr">39</xref>]</p><p>The present study demonstrated good soft and hard tissue response after treatment of intrabony defects with either DFDBA alone or in combination with PRP. Both treatment groups showed a significant PD reduction, CAL gain, hard-tissue fill and bone-depth reduction at 6 months after surgery compared to baseline. Addition of PRP to DFDBA did not show any significant improvement in clinical parameters, except plaque index at 3 months and probing pocket depth at 6 months. However, radiographic defect fill showed a significant improvement in PRP + DFDBA group than in DFDBA group at 6 months, postoperatively. The limitations of the present study were a small sample size, shorter follow-up period, absence of re-entry and non-digital radiographic evaluation.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Within limits of the present study, combination of DFDBA + PRP, though effective in improving radiologic parameters did not enhance clinical outcome of therapy compared to DFDBA alone. Long-term trials, large samples and histological examination are needed to evaluate regenerative potential of this combination. Further studies using PRP are necessary to examine the individual role played by PRP in achieving such results.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piemontese</surname><given-names>M</given-names></name><name><surname>Aspriello</surname><given-names>SD</given-names></name><name><surname>Rubini</surname><given-names>C</given-names></name><name><surname>Ferrante</surname><given-names>L</given-names></name><name><surname>Procaccini</surname><given-names>M</given-names></name></person-group><article-title>Treatment of periodontal intrabony defects with demineralized freeze-dried bone allograft in combination with platelet-rich plasma: A comparative clinical trial</article-title><source>J Periodontol</source><year>2008</year><volume>79</volume><fpage>802</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">18454658</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parimala</surname><given-names>M</given-names></name><name><surname>Mehta</surname><given-names>DS</given-names></name></person-group><article-title>Comparative evaluation of bovine porous bone mineral</article-title><source>J Indian Soc Periodontol</source><year>2010</year><volume>14</volume><fpage>126</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">21691551</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>MM</given-names></name><name><surname>Eber</surname><given-names>RM</given-names></name><name><surname>Korsnes</surname><given-names>MI</given-names></name><name><surname>MacNeil</surname><given-names>RL</given-names></name><name><surname>Glickman</surname><given-names>GN</given-names></name><name><surname>Shyr</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Evaluation of bioactive glass alloplast in treating periodontal intrabony defects</article-title><source>J Periodontol</source><year>1998</year><volume>69</volume><fpage>1346</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">9926764</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>E</given-names></name><name><surname>Rose</surname><given-names>LF</given-names></name></person-group><article-title>Biologic and clinical considerations for autografts and allografts in periodontal regeneration therapy</article-title><source>Dent Clin North Am</source><year>1998</year><volume>42</volume><fpage>467</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">9700450</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camargo</surname><given-names>PM</given-names></name><name><surname>Lekovic</surname><given-names>V</given-names></name><name><surname>Weinlaender</surname><given-names>M</given-names></name><name><surname>Vasilic</surname><given-names>N</given-names></name><name><surname>Madzarevic</surname><given-names>M</given-names></name><name><surname>Kenney</surname><given-names>EB</given-names></name></person-group><article-title>Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans</article-title><source>J Periodontal Res</source><year>2002</year><volume>37</volume><fpage>300</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12200975</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lekovic</surname><given-names>V</given-names></name><name><surname>Camargo</surname><given-names>PM</given-names></name><name><surname>Weinlaender</surname><given-names>M</given-names></name><name><surname>Vasilic</surname><given-names>N</given-names></name><name><surname>Kenney</surname><given-names>EB</given-names></name></person-group><article-title>Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: A reentry study</article-title><source>J Periodontol</source><year>2002</year><volume>73</volume><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">11895286</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Obarrio</surname><given-names>JJ</given-names></name><name><surname>Arauz-Dutari</surname><given-names>JI</given-names></name><name><surname>Chamberlain</surname><given-names>TM</given-names></name><name><surname>Croston</surname><given-names>A</given-names></name></person-group><article-title>The use of autologous growth factors in periodontal surgical therapy: Platelet gel biotechnology &#x02013; Case reports</article-title><source>Int J Periodontics Restorative Dent</source><year>2000</year><volume>20</volume><fpage>486</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">11203586</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarson</surname><given-names>NE</given-names></name><name><surname>Roach</surname><given-names>RB</given-names></name></person-group><article-title>Platelet rich plasma-clinical applications in dentistry</article-title><source>J Am Dent Assoc</source><year>2002</year><volume>33</volume><fpage>1383</fpage><lpage>6</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isidor</surname><given-names>F</given-names></name><name><surname>Karring</surname><given-names>T</given-names></name><name><surname>Attstrom</surname><given-names>R</given-names></name></person-group><article-title>Reproductivity of pocket depth and attachment level measurements when using a flexible splint</article-title><source>J Periodontol</source><year>1984</year><volume>11</volume><fpage>662</fpage><lpage>8</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benn</surname><given-names>DK</given-names></name></person-group><article-title>A computer-assisted method for making linear radiographic measurements using stored regions of interest</article-title><source>J Clin Periodontol</source><year>1992</year><volume>19</volume><fpage>441</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1430278</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subbaiah</surname><given-names>R</given-names></name><name><surname>Thomas</surname><given-names>B</given-names></name></person-group><article-title>Efficacy of a bioactive alloplast, in the treatment of human periodontal osseous defects-a clinical study</article-title><source>Med Oral Patol Oral Cir Bucal</source><year>2011</year><volume>16</volume><fpage>e239</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">21196894</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marx</surname><given-names>RE</given-names></name><name><surname>Carlson</surname><given-names>ER</given-names></name><name><surname>Eichstaedt</surname><given-names>RM</given-names></name><name><surname>Schimmele</surname><given-names>SR</given-names></name><name><surname>Strauss</surname><given-names>JE</given-names></name><name><surname>Joergeff</surname><given-names>KR</given-names></name></person-group><article-title>Platelet-rich plasma-growth factor enhancement for bone grafts</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>1998</year><volume>85</volume><fpage>638</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">9638695</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>Z</given-names></name><name><surname>Mellonig</surname><given-names>JT</given-names></name><name><surname>Carnes</surname><given-names>DL</given-names><suffix>Jr</suffix></name><name><surname>De LaFontaine</surname><given-names>L</given-names></name><name><surname>Cochran</surname><given-names>DL</given-names></name><name><surname>Dean</surname><given-names>DD</given-names></name><etal/></person-group><article-title>Ability of commercial Demineralized Freeze Dried Bone Allograft to induce new bone formation</article-title><source>J Periodontol</source><year>1996</year><volume>67</volume><fpage>918</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">8884650</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitman</surname><given-names>DH</given-names></name><name><surname>Berry</surname><given-names>RL</given-names></name><name><surname>Green</surname><given-names>DM</given-names></name></person-group><article-title>Platelet Gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery</article-title><source>J Oral Maxillofac Surg</source><year>1997</year><volume>55</volume><fpage>1294</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9371122</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sammartino</surname><given-names>G</given-names></name><name><surname>Tia</surname><given-names>M</given-names></name><name><surname>Marenzi</surname><given-names>G</given-names></name><name><surname>Lauro</surname><given-names>AE</given-names></name><name><surname>Agostino</surname><given-names>E</given-names></name><name><surname>Claudio</surname><given-names>PP</given-names></name></person-group><article-title>Use of autologous platelet rich plasma (PRP) in periodontal defect treatment after extraction of impacted mandibular third molars</article-title><source>J Oral Maxillofac Surg</source><year>2005</year><volume>63</volume><fpage>766</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">15944972</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowers</surname><given-names>GM</given-names></name><name><surname>Chadroff</surname><given-names>B</given-names></name><name><surname>Carnevale</surname><given-names>R</given-names></name><name><surname>Mellonig</surname><given-names>J</given-names></name><name><surname>Corio</surname><given-names>R</given-names></name><name><surname>Emerson</surname><given-names>J</given-names></name></person-group><article-title>Histological evaluation of new attachment apparatus formation in humans- Part II</article-title><source>J Periodontol</source><year>1989</year><volume>12</volume><fpage>675</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">2614632</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>S</given-names></name></person-group><article-title>Periodontal regeneration around natural teeth</article-title><source>Ann Periodontol</source><year>1996</year><volume>1</volume><fpage>621</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">9118274</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>H</given-names></name><name><surname>Joseph</surname><given-names>PF</given-names></name><name><surname>David</surname><given-names>WP</given-names></name><name><surname>Steven</surname><given-names>O</given-names></name><name><surname>William</surname><given-names>VG</given-names></name><name><surname>Samuel</surname><given-names>EL</given-names></name></person-group><article-title>A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease</article-title><source>J Periodontol</source><year>1997</year><volume>68</volume><fpage>1186</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">9444594</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname><given-names>K</given-names></name><name><surname>Tai</surname><given-names>H</given-names></name><name><surname>Tanabe</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Kawase</surname><given-names>T</given-names></name><etal/></person-group><article-title>Platelet Rich Plasma combined with porous hydroxyapatite graft for the treatment of intrabony periodontal defect in humans-A comparative controlled clinical study</article-title><source>J Periodontol</source><year>2005</year><volume>76</volume><fpage>890</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15948682</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassolis</surname><given-names>JD</given-names></name><name><surname>Rosen</surname><given-names>PS</given-names></name><name><surname>Reynolds</surname><given-names>MA</given-names></name></person-group><article-title>Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze dried bone allograft: Case series</article-title><source>J Periodontol</source><year>2000</year><volume>71</volume><fpage>1654</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">11063400</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lekovic</surname><given-names>V</given-names></name><name><surname>Camargo</surname><given-names>PM</given-names></name><name><surname>Weinlaender</surname><given-names>M</given-names></name><name><surname>Vasillic</surname><given-names>N</given-names></name><name><surname>Aleksic</surname><given-names>Z</given-names></name><name><surname>Kenney</surname><given-names>EB</given-names></name></person-group><article-title>Effectiveness of a combination of Platelet Rich Plasma, bovine porous bone mineral and GTR in treatment of mandibular G-II molar furcation in humans</article-title><source>J Clin Periodontol</source><year>2003</year><volume>30</volume><fpage>746</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">12887344</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapoff</surname><given-names>CA</given-names></name><name><surname>Bowers</surname><given-names>GM</given-names></name><name><surname>Levy</surname><given-names>B</given-names></name><name><surname>Mellonig</surname><given-names>JT</given-names></name><name><surname>Yukna</surname><given-names>RA</given-names></name></person-group><article-title>The effect of particle size on the osteogenic activity of composite grafts of allogeneic freeze-dried bone and autogenous marrow</article-title><source>J Periodontol</source><year>1980</year><volume>51</volume><fpage>625</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">7007609</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaskar</surname><given-names>SN</given-names></name><name><surname>Cutright</surname><given-names>DE</given-names></name><name><surname>Knapp</surname><given-names>MJ</given-names></name><name><surname>Beasley</surname><given-names>JD</given-names></name><name><surname>Perez</surname><given-names>B</given-names></name><name><surname>Driskell</surname><given-names>TD</given-names></name></person-group><article-title>Tissue reaction to intrabony ceramic implants</article-title><source>Oral Surg Oral Med Oral Pathol</source><year>1971</year><volume>31</volume><fpage>282</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">5277379</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortellini</surname><given-names>P</given-names></name><name><surname>Pini-Prato</surname><given-names>G</given-names></name><name><surname>Tonetti</surname><given-names>M</given-names></name></person-group><article-title>Periodontal regeneration of human infrabony defects (V): Effect of oral hygiene on long-term stability</article-title><source>J Clin Periodontol</source><year>1994</year><volume>21</volume><fpage>606</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">7806677</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yukna</surname><given-names>RA</given-names></name><name><surname>Krauser</surname><given-names>JT</given-names></name><name><surname>Callan</surname><given-names>DP</given-names></name><name><surname>Evans</surname><given-names>GH</given-names></name><name><surname>Cruz</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>M</given-names></name></person-group><article-title>Multi-centre clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects.6-months results</article-title><source>J Periodontol</source><year>2000</year><volume>71</volume><fpage>1671</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11128913</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srikanth</surname></name><name><surname>Sunil</surname><given-names>S</given-names></name><name><surname>Bennete</surname><given-names>AF</given-names></name><name><surname>Ravindra</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of efficacy of Natgraft (Bovine hydroxyapatite) granules in the treatment of human periodontal osseous defects-A clinical and radiographic study</article-title><source>J Indian Soc Periodontol</source><year>2003</year><volume>6</volume><fpage>75</fpage><lpage>82</lpage></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>C</given-names></name><name><surname>Mellonig</surname><given-names>J</given-names></name><name><surname>Brunsvold</surname><given-names>M</given-names></name><name><surname>McDonell</surname><given-names>H</given-names></name><name><surname>Cochran</surname><given-names>D</given-names></name></person-group><article-title>Clinical evaluation of Bio-Oss. A bovinederived xenograft for the treatment of periodontal osseousdefects in humans</article-title><source>J Clin Periodontol</source><year>1999</year><volume>26</volume><fpage>421</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10412845</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname><given-names>SA</given-names></name><name><surname>Rogalski</surname><given-names>JB</given-names></name><name><surname>Mills</surname><given-names>MP</given-names></name><name><surname>Arnold</surname><given-names>RM</given-names></name><name><surname>Cochran</surname><given-names>DL</given-names></name><name><surname>Mellonig</surname><given-names>JT</given-names></name></person-group><article-title>Evaluation of demineralized bone matrix paste and putty in periodontal intraosseous defects</article-title><source>J Periodontol</source><year>2005</year><volume>76</volume><fpage>768</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">15898938</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanna</surname><given-names>R</given-names></name><name><surname>Trejo</surname><given-names>PM</given-names></name><name><surname>Weltman</surname><given-names>RL</given-names></name></person-group><article-title>Treatment of intrabony defects with bovine-derived xenograft alone and in combination with platelet rich plasma: A randomized clinical trial</article-title><source>J Periodontol</source><year>2004</year><volume>75</volume><fpage>1668</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">15732870</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wikesjo&#x000a8;</surname><given-names>UM</given-names></name><name><surname>Nilvexus</surname><given-names>RE</given-names></name><name><surname>Selvig</surname><given-names>KA</given-names></name></person-group><article-title>Significance of early healing events on periodontal repair: A review</article-title><source>J Periodontol</source><year>1992</year><volume>63</volume><fpage>158</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">1593409</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camargo</surname><given-names>PM</given-names></name><name><surname>Lekovic</surname><given-names>V</given-names></name><name><surname>Weinlaender</surname><given-names>M</given-names></name><name><surname>Vasillic</surname><given-names>N</given-names></name><name><surname>Madzarevic</surname><given-names>M</given-names></name><name><surname>Kenny</surname><given-names>B</given-names></name></person-group><article-title>A re-entry study on the use of bovine porous bone mineral, GTR and Platelet rich Plasma in the regenerative treatment of intrabony defects in humans</article-title><source>Int J Periodont Rest Dent</source><year>2005</year><volume>25</volume><fpage>49</fpage><lpage>59</lpage></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Suh</surname><given-names>JJ</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Moon</surname><given-names>IS</given-names></name><name><surname>Cho</surname><given-names>KS</given-names></name><name><surname>Kim</surname><given-names>CK</given-names></name></person-group><article-title>Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects</article-title><source>J Periodontol</source><year>2001</year><volume>72</volume><fpage>730</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">11453234</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovelace</surname><given-names>TB</given-names></name><name><surname>Mellonig</surname><given-names>JT</given-names></name><name><surname>Meffert</surname><given-names>RM</given-names></name><name><surname>Jones</surname><given-names>AA</given-names></name><name><surname>Nummikoski</surname><given-names>PV</given-names></name><name><surname>Cochran</surname><given-names>DL</given-names></name></person-group><article-title>Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans</article-title><source>J Periodontol</source><year>1998</year><volume>69</volume><fpage>1027</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">9776031</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aghaloo</surname><given-names>TL</given-names></name><name><surname>Moy</surname><given-names>PK</given-names></name><name><surname>Freymiller</surname><given-names>EG</given-names></name></person-group><article-title>Evaluation of platelet-rich plasma in combination with freeze-dried bone in the rabbit cranium. A pilot study</article-title><source>Clin Oral Implants Res</source><year>2005</year><volume>16</volume><fpage>250</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15777336</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiltfang</surname><given-names>J</given-names></name><name><surname>Kloss</surname><given-names>FR</given-names></name><name><surname>Kessler</surname><given-names>P</given-names></name><name><surname>Nkenke</surname><given-names>E</given-names></name><name><surname>Schultze-Mosgau</surname><given-names>S</given-names></name><name><surname>Zimmermann</surname><given-names>R</given-names></name><etal/></person-group><article-title>Effects of platelet-rich plasma on bone healing in combination with autogenous bone and bone substitutes in critical size defects. An animal experiment</article-title><source>Clin Oral Implants Res</source><year>2004</year><volume>15</volume><fpage>187</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">15008930</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assoian</surname><given-names>RK</given-names></name></person-group><article-title>Biphasic effects of type beta transforming growth factor on epidermal growth factor receptors in NRK fibroblast. Functional consequences for epidermal growth factor-stimulated mitosis</article-title><source>J Biol Chem</source><year>1985</year><volume>260</volume><fpage>9613</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">2991254</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camargo</surname><given-names>PM</given-names></name><name><surname>Lekovic</surname><given-names>V</given-names></name><name><surname>Weinlaender</surname><given-names>M</given-names></name><name><surname>Divnic-Resnik</surname><given-names>T</given-names></name><name><surname>Pavlovic</surname><given-names>M</given-names></name><name><surname>Kenney</surname><given-names>EB</given-names></name></person-group><article-title>A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans</article-title><source>J Periodontol</source><year>2009</year><volume>80</volume><fpage>915</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">19485821</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lekovic</surname><given-names>V</given-names></name><name><surname>Milinkovic</surname><given-names>I</given-names></name><name><surname>Aleksic</surname><given-names>Z</given-names></name><name><surname>Jankovic</surname><given-names>S</given-names></name><name><surname>Stankovic</surname><given-names>P</given-names></name><name><surname>Kenney</surname><given-names>EB</given-names></name><etal/></person-group><article-title>Platelet-rich fibrin and bovine porous bone mineral vs. platelet-rich fibrin in the treatment of intrabony periodontal defects</article-title><source>J Periodontal Res</source><year>2012</year><volume>47</volume><fpage>409</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">22126591</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000f6;ri</surname><given-names>F</given-names></name><name><surname>Kov&#x000e1;cs</surname><given-names>V</given-names></name><name><surname>Arweiler</surname><given-names>NB</given-names></name><name><surname>Husz&#x000e1;r</surname><given-names>T</given-names></name><name><surname>Gera</surname><given-names>I</given-names></name><name><surname>Nikolidakis</surname><given-names>D</given-names></name><etal/></person-group><article-title>Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: A pilot study</article-title><source>J Periodontol</source><year>2009</year><volume>80</volume><fpage>1599</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">19792848</pub-id></element-citation></ref></ref-list></back></article>